How Common Is Antithrombin III Deficiency?

Antithrombin III deficiency is considered a rare condition. According to medical data, approximately one person in every 2,000 to 3,000 people has this deficiency.^[1] Among individuals who experience blood clots in their veins, somewhere between 1% and 5% have antithrombin deficiency as the underlying cause.^[5] While the inherited form affects a smaller portion of the population, acquired forms of this deficiency can be more common in certain clinical situations.

The rarity of this condition means that many people may go undiagnosed for years, sometimes only discovering they have antithrombin deficiency after experiencing their first serious blood clot. Some estimates suggest that between 65,000 and 650,000 people in the United States may be affected by hereditary antithrombin deficiency, though the wide range reflects uncertainty about how many cases remain undetected.^[7]

Despite its rarity, antithrombin deficiency carries one of the highest risks for blood clots among all inherited clotting disorders. People with this condition are about 20 times more likely to develop a venous thromboembolism (a blood clot in a vein) compared to the general population.^[7] This significantly elevated risk makes early diagnosis and appropriate management crucial for preventing life-threatening complications.

What Causes Antithrombin III Deficiency?

The hereditary form of antithrombin III deficiency occurs when a person inherits a mutation in the SERPINC1 gene, also called the AT3 gene, which is located on chromosome 1.^[1] This gene provides instructions for making the antithrombin protein, which plays a vital role in controlling blood clot formation. When the gene contains errors, the body either produces insufficient amounts of antithrombin or makes antithrombin that does not work properly.

Most cases of inherited antithrombin deficiency follow an autosomal dominant pattern of inheritance.^[3] This means that inheriting just one defective copy of the gene from one parent is enough to cause the condition. Each child of an affected parent has a 50% chance of inheriting the mutation, regardless of whether they are male or female.^[1] However, not everyone who inherits the mutation will necessarily develop blood clots, as other factors also influence whether symptoms appear.

Beyond the inherited form, antithrombin deficiency can also be acquired during a person’s lifetime. Acquired deficiency occurs when the body uses up antithrombin faster than it can produce it, or when production decreases. This can happen in several medical situations, including disseminated intravascular coagulation (a serious condition where clotting occurs throughout the body), severe infections like sepsis, liver disease, kidney disease with protein loss, and certain treatments including heparin administration.^[3][11] Oral contraceptives have also been associated with lower antithrombin levels.

Who Is at Higher Risk?

The most significant risk factor for developing problems from antithrombin III deficiency is having a family history of the condition. Since the hereditary form passes from parent to child, anyone with a close family member who has been diagnosed should consider screening, especially if that family member experienced blood clots at a young age.^[4]

Approximately 50% of people with hereditary antithrombin deficiency will develop at least one blood clot during their lifetime, usually after adolescence.^[7] The risk increases substantially with age. Studies show that about 85% of patients with hereditary deficiency will have at least one clotting event by age 50, with roughly 70% experiencing their first clot before age 35.^[7] About six in ten patients with this condition will have blood clots that recur, meaning they experience more than one clotting episode over time.^[7]

Certain situations dramatically increase the risk of developing blood clots in people with antithrombin deficiency. Surgery is a major risk factor, as the body’s clotting system becomes more active during and after surgical procedures. Prolonged immobility, such as during long flights or extended bed rest, also raises the risk significantly because blood flow slows down when the body remains still for long periods.

Pregnancy and the period after childbirth represent particularly high-risk times for women with antithrombin deficiency. Between 3% and 70% of pregnant women with this condition may develop blood clots during pregnancy or after delivery, with some studies suggesting that up to 70% may experience clotting complications.^[1][7] The wide range reflects different study populations, but the elevated risk during pregnancy is clear and consistent across research.

Additional factors that can increase risk include obesity and abnormal blood fat levels (dyslipidemia), both of which are independently associated with higher clotting risk.^[11] Hormonal treatments, including estrogen therapy for menopause symptoms and birth control pills, can also precipitate clotting events in susceptible individuals, which is why women with known antithrombin deficiency are generally advised to avoid oral contraceptives.^[11]

What Symptoms Should People Watch For?

The hallmark symptom of antithrombin III deficiency is the development of abnormal blood clots, particularly in the veins. The two most common types of clots are deep vein thrombosis (DVT), which typically occurs in the deep veins of the legs, and pulmonary embolism (PE), which happens when a clot breaks free and travels to the lungs.^[1] These are the conditions that most frequently bring the deficiency to medical attention.

Deep vein thrombosis in the legs typically causes swelling, redness, warmth, and pain in the affected limb. The swelling may make one leg noticeably larger than the other. The pain often intensifies when standing or walking and may feel like a cramp or ache that doesn’t go away with rest.^[4] Some people describe a feeling of heaviness in the affected leg.

When a blood clot travels to the lungs and causes a pulmonary embolism, symptoms can include sudden shortness of breath, chest pain that worsens with deep breathing, rapid heart rate, coughing (sometimes with bloody sputum), and feelings of anxiety or lightheadedness.^[4] Pulmonary embolism is a medical emergency that requires immediate treatment, as it can be life-threatening.

While less common, blood clots can also form in unusual locations in people with antithrombin deficiency. Clots have been reported in veins of the brain, abdomen (including mesenteric veins that supply the intestines), and near the umbilical area.^[1][11] Arterial clots, though rare, have also been documented in some patients with this condition.^[11]

The timing of the first clot is an important characteristic of antithrombin deficiency. Most people with this condition experience their first blood clot before age 40, and many have their first event in young adulthood.^[1] Having a blood clot at an unusually young age, especially without obvious triggers like surgery or injury, should prompt investigation for antithrombin deficiency and other inherited clotting disorders.

How Can Antithrombin III Deficiency Be Prevented?

Since hereditary antithrombin III deficiency is a genetic condition present from birth, preventing the condition itself is not possible. However, preventing the complications—particularly blood clots—is the primary focus of care for people with this diagnosis. Once close family members know that antithrombin deficiency runs in the family, screening can identify who carries the mutation, allowing for preventive measures before the first clot occurs.^[4]

Lifestyle modifications play an important role in reducing clot risk. Regular physical activity helps maintain healthy blood circulation and can reduce the likelihood of clots forming during periods of rest. Maintaining a healthy body weight is also beneficial, as obesity is an independent risk factor for blood clots. People with antithrombin deficiency should avoid smoking, which damages blood vessels and increases clotting risk.

Staying well-hydrated helps keep blood flowing smoothly and prevents it from becoming too thick or sluggish. During long periods of sitting, such as during air travel or long car rides, people should make efforts to move around regularly, flex their leg muscles, and avoid crossing their legs for extended periods. These simple measures help prevent blood from pooling in the legs, which can trigger clot formation.

Women with antithrombin deficiency face special considerations regarding hormonal medications. Oral contraceptives and estrogen replacement therapy can increase clotting risk, so women with this condition should discuss alternative options with their healthcare providers.^[11] During pregnancy, close monitoring and often preventive treatment with blood-thinning medications are necessary to protect both mother and baby from clotting complications.

For people undergoing surgery or other medical procedures, communication with the healthcare team about antithrombin deficiency is crucial. Preventive measures, which might include blood-thinning medications or antithrombin concentrate replacement, can be implemented around the time of surgery to minimize risk during this vulnerable period.

How Does Antithrombin III Deficiency Affect the Body?

To understand how antithrombin III deficiency affects the body, it helps to know what antithrombin normally does. Antithrombin is a protein that circulates in the blood and acts as a natural brake on the clotting system. When blood vessels are damaged and bleeding occurs, the body activates a complex series of reactions called the coagulation cascade, which involves many different clotting factors working in sequence to form a blood clot and stop the bleeding.

Antithrombin works by binding to and inactivating several key players in this coagulation cascade, particularly thrombin (also called factor IIa), factor Xa, and factor IXa.^[3][6] These are serine protease enzymes that drive the clotting process forward. By neutralizing these enzymes, antithrombin prevents clotting from continuing indefinitely and helps the body maintain a healthy balance—clotting enough to stop bleeding at injury sites, but not so much that dangerous clots form in intact blood vessels.

The action of antithrombin becomes much more powerful when it binds with heparin, a molecule found naturally on the surface of blood vessel walls and also used as a blood-thinning medication. When heparin attaches to antithrombin, it causes a change in the antithrombin’s shape that dramatically increases its ability to shut down clotting factors—by as much as 1,000-fold.^[6][10] This is actually the main way that heparin medications work to prevent blood clots.

In people with antithrombin III deficiency, levels of functional antithrombin typically drop to between 40% and 60% of normal.^[7] Without enough antithrombin to apply the brakes, the coagulation cascade can become overactive. The analogy used in medical education is that of filling a bathtub with water but having no one there to turn off the tap—the water (or in this case, the clotting process) just keeps going and eventually overflows.^[1]

This excessive clotting activity leads to the formation of blood clots inside intact blood vessels, particularly in the veins where blood flow is naturally slower. These clots can grow large enough to block blood flow, depriving tissues of oxygen and nutrients. If a clot breaks loose, it can travel through the bloodstream and lodge in vital organs like the lungs, potentially causing life-threatening complications.

Beyond its role in controlling clotting, antithrombin also has anti-inflammatory properties. It can interact with cells lining blood vessels and help regulate inflammatory responses.^[10] When antithrombin levels are deficient, this protective anti-inflammatory effect is diminished, which may contribute to tissue damage during clotting events.